mefenamic acid has been researched along with Kidney Failure, Chronic in 5 studies
Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Non-oliguric renal failure developed in six elderly women who had been prescribed 1--2 g of mefenamic acid daily for 2--6 weeks for the relief of musculoskeletal pain." | 3.66 | Mefenamic acid nephropathy. ( Dlugolecka, M; Ford, MJ; Prescott, LF; Robertson, CE; Van Someren, V, 1980) |
| " The study suggests that adjustment of mefenamic acid dosage is not necessary in patients undergoing hemodialysis and that hemodialysis is of minimal value in the management of mefenamate overdose." | 1.26 | Hemodialysis of mefenamic acid in uremic patients. ( Lee, CS; Marbury, TC; Wang, LH, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robertson, CE | 1 |
| Ford, MJ | 1 |
| Van Someren, V | 1 |
| Dlugolecka, M | 1 |
| Prescott, LF | 1 |
| Wang, LH | 1 |
| Lee, CS | 1 |
| Marbury, TC | 1 |
| Grant, DJ | 1 |
| MacConnachie, AM | 1 |
| Itami, N | 1 |
| Akutsu, Y | 1 |
| Yasoshima, K | 1 |
| Tochimaru, H | 1 |
| Takekoshi, Y | 1 |
| Matsumoto, S | 1 |
| Boletis, J | 1 |
| Williams, AJ | 1 |
| Shortland, JR | 1 |
| Brown, CB | 1 |
5 other studies available for mefenamic acid and Kidney Failure, Chronic
| Article | Year |
|---|---|
Mefenamic acid nephropathy.
Topics: Aged; Creatinine; Female; Humans; Kidney Concentrating Ability; Kidney Failure, Chronic; Mefenamic A | 1980 |
Hemodialysis of mefenamic acid in uremic patients.
Topics: Adult; Humans; Kidney Failure, Chronic; Male; Mefenamic Acid; Metabolic Clearance Rate; Middle Aged; | 1980 |
Non-steroidal anti-inflammatory drugs in elderly people. Mefenamic acid is more dangerous than most.
Topics: Aged; Gastrointestinal Hemorrhage; Humans; Kidney Failure, Chronic; Mefenamic Acid; Risk Factors | 1995 |
Progressive renal failure despite discontinuation of mefenamic acid.
Topics: Adolescent; Creatinine; Glomerulosclerosis, Focal Segmental; Humans; Kidney Failure, Chronic; Male; | 1990 |
Irreversible renal failure following mefenamic acid.
Topics: Fibrosis; Humans; Kidney Failure, Chronic; Male; Mefenamic Acid; Middle Aged; Nephritis, Interstitia | 1989 |